Sanofi puts new CSO in Boston, adding more weight to U.S. R&D

Sanofi's ($SNY) center of gravity is continuing its shift toward the U.S. The French drugmaker not only recruited a top official at the National Institutes of Health to be its chief scientific officer. It also decided to place him in the Boston area, where it set up an R&D hub last year. Report